|
Delayed
Nasdaq Stockholm
05:59:25 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 1.840 SEK | +0.77% |
|
-3.16% | -6.60% |
| 09-03 | Irlab CEO Kristina Torfgaard to step down in 2027 | FW |
| 09-03 | Irlab CEO Kristina Torfgaard wants to step down | FW |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
| 27.02M | - | - | - | - | - | - | - | ||
| 1,025B | A | ||||||||
| 623B | BBB | ||||||||
| 459B | AAA | - | |||||||
| 355B | A | ||||||||
| 336B | AA | ||||||||
| 270B | AAA | ||||||||
| 247B | A | ||||||||
| 220B | A | ||||||||
| 183B | AA | ||||||||
| 166B | BBB | ||||||||
| 160B | A | ||||||||
| 128B | AA | ||||||||
| 126B | A | ||||||||
| 105B | - | AA | - | - | |||||
| 98.6B | A | ||||||||
| 95.02B | AA | ||||||||
| 75.43B | - | BBB | - | - | |||||
| 73.37B | BBB | ||||||||
| 65.81B | AAA | ||||||||
| Average | 240.6B | AA | |||||||
| Weighted average by Cap. | AA |
- Stock Market
- Stocks
- IRLAB A Stock
- Sector IRLAB Therapeutics AB
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
















